Individually, HIF1α has been associated with the metabolic reprogramming of glycolysis, the expression of genes involved in apoptotic cell death, and the suppression of anti-tumor immune effects [65], while HIF2α has been associated with the maintenance of GSCs and an immunosuppressive phenotype in tumor-associated macrophages [62,66]. Here, HIF1A is linked to neoplasm.